Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Elizabeth Murray a Department of
Primary Care and Population Sciences, Royal Free and University College
Medical School, University College London, London N19 3UA, b Picker
Institute Europe, Oxford OX1 1RX, c Health Economics Research
Centre, University of Oxford, Oxford OX3 7LF
Correspondence to: E Murray elizabeth.murray{at}pcps.ucl.ac.uk
Objective:
To determine whether a decision aid on
hormone replacement therapy influences decision making and health outcomes.
What is already known on this topic
What this study adds
Design:
Randomised controlled trial.
Setting:
26 general practices in the United Kingdom.
Participants:
205 women considering hormone
replacement therapy.
Intervention:
Patients' decision aid consisting of an
interactive multimedia programme with booklet and printed summary.
Outcome measures:
Patients' and general
practitioners' perceptions of who made the decision, decisional
conflict, treatment choice, menopausal symptoms, costs, anxiety, and
general health status.
Results:
Both patients and general practitioners found the decision aid acceptable. At three months, mean scores for decisional conflict were significantly lower in the intervention group
than in the control group (2.5 v 2.8; mean difference
0.3, 95% confidence interval
0.5 to
0.2); this difference was
maintained during follow up. A higher proportion of general
practitioners perceived that treatment decisions had been made
"mainly or only" by the patient in the intervention group than in
the control group (55% v 31%; 24%, 8% to 40%). At three
months a lower proportion of women in the intervention group than in
the control group were undecided about treatment (14% v
26%;
12%,
23% to
0.4%), and a higher proportion had
decided against hormone replacement therapy (46% v 32%;
14%, 1% to 28%); these differences were no longer apparent by nine
months. No differences were found between the groups for anxiety, use
of health service resources, general health status, or utility. The
higher costs of the intervention were largely due to the video disc
technology used.
Conclusions:
An interactive multimedia decision aid in the NHS would be popular with patients, reduce decisional conflict, and
let patients play a more active part in decision making without increasing anxiety. The use of web based technology would reduce the
cost of the intervention.
Patients want more information about their conditions and treatment
options, and many want to play an active part in decision
making
The decision aid was acceptable to both the patients and their general
practitioners
Read all Rapid Responses